Search results for "GebFra Science"

showing 7 items of 7 documents

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

2019

AbstractThe article gives an overview of current treatment options for metastatic hormone receptor-positive and HER2-negative breast cancer. The focus is on combined therapies, e.g., with CDK4/6 inhibition compared with purely endocrine-based therapies in the pre- and postmenopause, presenting the latest study results. The addition of a CDK4/6 inhibitor to endocrine-based therapy with an aromatase inhibitor or fulvestrant leads to a marked improvement in progression-free survival and is independently beneficial whether palbociclib, ribociclib or abemaciclib is involved. The particular clinical status of inhibition of cyclin-dependent kinases argues for its use in the first-line treatment of…

CDK4/6-InhibitorOncologymedicine.medical_specialtymedicine.drug_classMetastasierungPalbociclibCDK4/6 inhibitorHER2-negativMetastasisMammakarzinom03 medical and health scienceschemistry.chemical_compoundbreast cancer0302 clinical medicineBreast cancerInternal medicineMaternity and MidwiferyReview/ÜbersichtmetastasisEndocrine systemMedicineGebFra ScienceAbemaciclib030219 obstetrics & reproductive medicineAromatase inhibitorFulvestrantbusiness.industryhormonrezeptorpositivObstetrics and Gynecologymedicine.diseasechemistryHormone receptorhormone receptor-positivebusinessHER2-negativemedicine.drugGeburtshilfe und Frauenheilkunde
researchProduct

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

2021

Geburtshilfe und Frauenheilkunde 81(10), 1101-1111 (2021). doi:10.1055/a-1519-7089

Evidence-based practicePerformance statusbusiness.industryObstetrics and GynecologyTreatment optionsRecommendationmedicine.diseasetherapy algorithmsPatient preferenceMetastatic breast cancerevidence-based treatmentBreast cancerevidenzbasierte TherapieMaternity and Midwiferybreast cancer guidelinesmedicineTreatment decision makingGebFra ScienceBehandlungsalgorithmenbusinessAlgorithmBrustkrebs-Leitlinien
researchProduct

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032…

2018

Geburtshilfe und Frauenheilkunde 78(11), 1056-1088 (2018). doi:10.1055/a-0646-4630

medicine.medical_specialtyAdvanced breastPsychological interventionGuideline/LeitlinieSystemic therapymetastasiertes Mammakarzinomprimary breast cancer03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerMaternity and MidwiferyBrustkrebsMedicineprimäres Mammakarzinom030212 general & internal medicineGebFra ScienceIntensive care medicineLeitlinietherapybusiness.industryTumor biologyObstetrics and GynecologyCancerGuidelinemedicine.diseaseMetastatic breast cancerddc:030220 oncology & carcinogenesismetastatic breast cancerbusinessTherapieguideline
researchProduct

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

2021

Geburtshilfe und Frauenheilkunde 81(10), 1112-1120 (2021). doi:10.1055/a-1499-8431

medicine.medical_specialtyAxillary lymph nodesBreast surgerymedicine.medical_treatmentMammakarzinomBreast cancerbreast cancerMaternity and MidwiferyAdjuvant therapymedicineddc:610GebFra ScienceStage (cooking)Sentinel-Lymphknoten-Entfernungtargeted axillary dissectionsentinel LNEneoadjuvante Chemotherapiebusiness.industryObstetrics and Gynecologymedicine.diseaseRadiation therapyDissectionAxillamedicine.anatomical_structuregezielte axilläre DissektionRadiologybusinessRecommendation/Empfehlungneoadjuvant chemotherapy
researchProduct

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032…

2018

62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, DGGG'18, Berlin, Germany, 31 Oct 2018 - 3 Nov 2018; Geburtshilfe und Frauenheilkunde 78(10), 927-948 (2018). doi:10.1055/a-0646-4522 special issue: "62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, DGGG'18, Berlin, 31.10 – 03.11.2018 : Frauenheilkunde im Fokus: wissenschaftlich fundiert und der Qualität verpflichtet"

medicine.medical_specialtydiagnosisPsychological interventionComputed tomographyDiseaseGuideline/LeitlinieMammakarzinom03 medical and health sciencesbreast cancerDiagnostik0302 clinical medicineBreast cancerMaternity and Midwiferyfollow-upmedicineMammographyMedical physicsGebFra Science030212 general & internal medicinemedicine.diagnostic_testbusiness.industryscreeningObstetrics and GynecologyCancerGuidelinemedicine.diseaseddc:030220 oncology & carcinogenesisFrüherkennungRichtlinieNachsorgebusinessguidelineSystematic searchGeburtshilfe und Frauenheilkunde
researchProduct

Ramadan Observance during Pregnancy in Germany: a Challenge for Prenatal Care.

2018

Abstract Introduction Fasting during Ramadan while pregnant has been shown to have long-term negative effects on the offspringʼs physical and cognitive health. Even though most Muslims do not believe pregnant women are obligated to fast during Ramadan, fasting rates of up to 87% have been reported for pregnant women. No data exists to date about Ramadan adherence and behavior in Germany. Methods The Mainz Study of Ramadan and Pregnancy surveyed pregnant Muslims and new Muslim mothers in Mainz between October 2016 and January 2017 and collected information on Ramadan adherence and behavior. We also collected data on personal characteristics and opinions, to identify determinants of fasting u…

medicine.medical_specialtyfastingPrenatal careCognitive healthSchwangerschaftsvorsorge03 medical and health sciences0302 clinical medicine0502 economics and businessMaternity and MidwiferyEpidemiologymedicineFrauenheilkundeStatistical analysisGebFra Science030212 general & internal medicine050207 economicsEpidemiologieRamadanPregnancybusiness.industrygynecology05 social sciencesSignificant differenceObstetrics and GynecologyOriginal Article/Originalarbeitmedicine.diseasehumanitiesCountry of originFamily medicineepidemiologyFastenprenatal careObjective informationbusinessGeburtshilfe und Frauenheilkunde
researchProduct

Fertility After Ovarian Cystectomy: How Does Surgery Affect IVF/ICSI Outcomes?

2019

Abstract Introduction For patients considering undergoing assisted reproductive techniques (ART), many concerns arise when persistent ovarian cysts are found. This large study aimed to determine how ovarian cyst removal affects success rates of IVF/ICSI therapies. Methods 550 patients who underwent an IVF/ICSI treatment between 2002 and 2011 with a persistent ovarian cyst ≤ 5 cm before treatment were analyzed retrospectively. 328 patientsʼ preference was to undergo a laparoscopic cystectomy and 222 patients opted for a conservative management. Control subjects included 13 552 patients undergoing IVF/ICSI at the same period of time without an ovarian cyst. Results After adjusting for age, pa…

medicine.medical_specialtyfertilization ratemedia_common.quotation_subjectFertilityovarian cystMaternity and MidwiferymedicineGebFra Scienceklinische SchwangerschaftsrateOvarialzysteOozytenzahlmedia_commonBefruchtungsrateLaparoscopic cystectomyOvarian cystbusiness.industryIVF/ICSIObstetrics and GynecologyIvf icsioocyte numberControl subjectsmedicine.diseaseclinical pregnancy ratesSurgeryPregnancy rateOriginal ArticleOvarian cystectomyLive birthbusinessGeburtshilfe und Frauenheilkunde
researchProduct